全基因组研究揭示了Shigella spp中的潜在治疗点
Md Arju Hossain1,2, Md Al Amin1, Md Arif Khan3,4
1Department of Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Tangail 1902, Bangladesh.
BioMed research international
|April 10, 2024
概括
耐多药西格拉菌株构成了全球健康威胁. 这项研究分析了全基因组序列,以确定抗生素耐药性基因和潜在的治疗标,揭示了排泄和标修饰作为关键的耐药性机制.
科学领域:
- 微生物学 微生物学
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 在全球范围内,西格拉菌是导致细菌性痢疾的主要原因,特别是在卫生条件差的地区.
- 多药耐药 (MDR) 滋格拉菌株的增加使治疗变得复杂,尤其是在医疗保健的获取有限的地方.
- 了解Shigella的抗生素耐药性机制对于开发新型治疗策略至关重要.
研究的目的:
- 分析人类病原性Shigella spp.的全基因组序列 (WGS). 为了确定抗生素耐药性基因 (ARGs).
- 阐明耐药性机制,基因药物相互作用,蛋白质蛋白质相互作用和功能途径.
- 选潜在的治疗候选人,以对抗MDR Shigella.
主要方法:
- 使用生物信息学工具对45个来自Shigella物种 (S. flexneri,S. dysenteriae,S. boydii,S. sonnei) 的WGS进行了全面分析.
- 遗传学分析,以了解菌株之间的进化关系.
- 预测和分析ARG,枢纽蛋白和相关途径.
主要成果:
- 在45个基因组中预测了2,146个ARG,共享了91个ARG. 抗药性主要由抗生素排泄 (51.0%) 和目标改变 (23%) 介导.
- 确定了13个枢纽蛋白,包括tolC,acrR,mdtA和gyrA,与关键的抵抗机制有关.
- 遗传学分析显示,在流通的西格拉菌株中,有三个不同的基因组,基因组多样性有限.
结论:
- 人类致病性西格拉菌株具有多种ARG,主要通过排泄和目标修改赋予耐药性.
- 已识别的枢纽蛋白 (例如,tolC,acrR,mdtA,gyrA) 代表了针对MDR Shigella的新疗法开发的有希望的目标.
- 研究结果强调,在制定有效的治疗策略时,需要考虑这些耐药性机制来对抗西格拉菌感染.
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...